A detailed history of Ubs Group Ag transactions in Inspire Md, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,363 shares of NSPR stock, worth $6,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,363
Holding current value
$6,403
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.36 - $3.39 $5,576 - $8,010
2,363 New
2,363 $6,000
Q4 2023

Feb 09, 2024

BUY
$2.06 - $3.77 $2,406 - $4,403
1,168 New
1,168 $3,000
Q2 2023

Aug 11, 2023

BUY
$0.98 - $2.73 $79 - $221
81 Added 78.64%
184 $0
Q1 2023

May 12, 2023

SELL
$0.87 - $1.32 $904 - $1,372
-1,040 Reduced 90.99%
103 $0
Q4 2022

Feb 08, 2023

SELL
$0.81 - $1.44 $4,117 - $7,319
-5,083 Reduced 81.64%
1,143 $0
Q3 2022

Nov 10, 2022

BUY
$1.48 - $2.07 $2,542 - $3,556
1,718 Added 38.11%
6,226 $9,000
Q2 2022

Aug 10, 2022

BUY
$1.89 - $3.27 $4,394 - $7,602
2,325 Added 106.5%
4,508 $9,000
Q1 2022

May 16, 2022

BUY
$2.39 - $3.23 $5,217 - $7,051
2,183 New
2,183 $7,000

Others Institutions Holding NSPR

About InspireMD, Inc.


  • Ticker NSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,323,200
  • Market Cap $22.6M
  • Description
  • InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...
More about NSPR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.